Business Context and Reporting Period
Cardinal Health, Inc. filed a Form 8-K Current Report on August 7, 2026. The filing details a significant restructuring of the company's short-term and medium-term liquidity facilities, specifically the entry into a new unsecured Credit Agreement and the termination of prior credit and receivables facilities.
Key Financial Metrics and Liquidity
- New Revolving Credit Facility: $4.0 billion unsecured revolving credit facility.
- Termination Date: August 7, 2031 (extendable by up to two years).
- Financial Covenant: Consolidated Net Leverage Ratio must not exceed 4.00 to 1.00 as of the last day of any fiscal quarter.
- Terminated Facilities:
- Five-Year Credit Agreement: $2.0 billion revolving credit.
- 364-Day Credit Agreement: $1.0 billion revolving credit.
- Receivables Purchase Agreement: $1.0 billion committed receivables sale program.
- Termination Penalties: None incurred.
Material Changes Versus Prior Period
The company consolidated three separate financing arrangements (totaling $4.0 billion in capacity) into a single $4.0 billion unsecured revolving credit facility. This change replaces the existing 364-day and five-year revolving credit facilities as well as the receivables sale facility program. The new agreement extends the maturity horizon to 2031, providing greater stability compared to the terminated 364-day facility.
Guidance, Outlook, and Risks
Management Commentary: The new Credit Agreement is intended for general corporate purposes. The agreement includes customary representations, affirmative and negative covenants, and events of default.
Risks and Contingencies: The primary financial risk is the maintenance of the Consolidated Net Leverage Ratio below 4.00 to 1.00. Failure to meet this covenant or other events of default (such as non-payment of principal or interest) could trigger adverse consequences. The filing notes that financial institutions involved may continue to provide commercial and investment banking services for which the company pays customary fees.
Investor Verification Checklist
- Verify the specific definition of "Consolidated Net Leverage Ratio" in the attached Credit Agreement (Exhibit 10.1) to understand calculation nuances.
- Confirm the current outstanding balance on the new $4.0 billion facility versus the terminated facilities to assess immediate liquidity impact.
- Review the "customary events of default" in the new agreement to identify any changes in default triggers compared to prior facilities.
- Check subsequent filings for any drawdowns on the new facility or changes in the company's leverage ratio.